Anti-Serpin-A11 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody targeting the amino-terminal region of mature human Serpin-A11, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-
UniProt
Q86U17
Size
100ug
Cat. #
RP2SerpinA11

In stock

SKU
RP-SerpinA11

Options

As low as: $130.00

Target Overview

Serpin-A11 (SERPINA11, UniProt Q86U17) is a secreted member of the serine protease inhibitor superfamily, comprising 422 amino acids in its mature form. Classified within the serpin clade A, Serpin-A11 shares the characteristic serpin fold but remains incompletely characterized with respect to its specific protease targets and physiological substrates. The protein is secreted into circulation and has been detected in plasma and exosomal fractions. Unlike classical hemostatic serpins such as antithrombin or alpha-1 antitrypsin, Serpin-A11 appears to function outside the canonical coagulation cascade. Researchers have shown interest in Serpin-A11 as a circulating biomarker in cardiovascular contexts and metabolic remodeling. Recent proteomic profiling studies have identified Serpin-A11 in exosomes and plasma fractions associated with atherosclerosis and blood pressure regulation, suggesting roles in vascular homeostasis that warrant further mechanistic investigation.

Background

The serpin superfamily comprises structurally conserved inhibitors that regulate proteolytic cascades in immunity, inflammation, coagulation, and extracellular matrix remodeling. Serpin-A11 is among the least studied members of clade A, and its endogenous protease target has not been definitively identified. Functional annotation has relied primarily on homology modeling and transcriptomic surveys rather than biochemical reconstitution. Its secreted localization and presence in exosomal cargo point toward paracrine or endocrine signaling roles. Emerging clinical data associate Serpin-A11 with cardiovascular and metabolic phenotypes. Kim et al. (2025) validated exosomal Serpin-A11 as a candidate atherosclerosis marker using bioprinted vascular scaffolds, demonstrating differential expression in atherogenic conditions. Pan et al. (2025) identified Serpin-A11 among plasma proteomic signatures linked to blood pressure management following bariatric surgery in adolescents, suggesting involvement in metabolic adaptation. A perinatal lethal serpinopathy caused by SERPINA11 mutation was reported by Aggarwal et al. (2024), establishing that loss-of-function or misfolding variants can produce severe developmental consequences, though the molecular mechanism remains under investigation. Serpin-A11 has also appeared in disease-associated proteomic datasets for chronic obstructive pulmonary disease and intracerebral hemorrhage, where it was nominated as a candidate prognostic biomarker. These observations position Serpin-A11 as a circulating factor with potential regulatory significance across vascular, metabolic, and respiratory pathophysiology. Triple Point Biologics offers three rabbit polyclonal antibodies raised against the amino-terminal region of mature Serpin-A11, validated for Western blot.

References

  1. Kim KS et al (2025) Validation of the exosomal protein SERPINA11 as a potential atherosclerosis marker via bioprinted scaffold. Biofabrication. PubMed · 10.1088/1758-5090/add8bf
  2. Pan S et al (2025) Plasma Metabolomic and Proteomic Signatures of Blood Pressure Management After Bariatric Surgery Among Adolescents. Hypertension. PubMed · 10.1161/HYPERTENSIONAHA.125.25261
  3. Aggarwal S et al (2024) SERPINA11 related novel serpinopathy - A perinatal lethal disorder. Clin Genet. PubMed · 10.1111/cge.14564
  4. Sharma G et al (2024) Meta-Analysis and DIA-MS-Based Proteomic Investigation of COPD Patients and Asymptomatic Smokers in the Indian Population. J Proteome Res. PubMed · 10.1021/acs.jproteome.4c00463
  5. Misra S et al (2024) Prognostic biomarkers of intracerebral hemorrhage identified using targeted proteomics and machine learning algorithms. PLoS One. PubMed · 10.1371/journal.pone.0296616

Additional Specifications

Gene Symbol SERPINA11
UniProt ID Q86U17
Host Species Rabbit
Species Reactivity Validated- Human
Potential-
Pack Size 100ug
Immunogen (Amino end mature Serpin-A11)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 20-70.
Immunogen (Helix 4 to Helix 5)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 150-220.
Immunogen (Helix 7 to Helix 8)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 280-350.
Alternate Names SERPINA11, Serpin A11

Frequently Asked Questions

What molecular weight should I expect for Serpin-A11 on Western blot?

Serpin-A11 migrates at approximately 47–50 kDa on reducing SDS-PAGE, corresponding to the 422-amino-acid mature secreted protein. The predicted molecular weight from sequence is around 46 kDa, but glycosylation and post-translational modifications can shift the apparent size upward. Because Serpin-A11 is secreted, you will detect it robustly in conditioned medium, serum, or plasma samples. If working with cell lysates, expect lower signal unless the cell type actively secretes Serpin-A11. Always include a positive control such as human plasma or serum to confirm antibody performance.

What dilution should I start with for Western blot with this Serpin-A11 antibody?

We recommend starting at 1:1000 dilution in blocking buffer for Western blot, which has been validated for this rabbit polyclonal. Depending on your sample type and Serpin-A11 abundance, you may optimize between 1:500 and 1:2000. Secreted samples such as plasma, serum, or conditioned medium typically yield strong signal at 1:1000. For cell lysates from non-secretory lines, consider concentrating your sample or using a more concentrated antibody dilution around 1:500. Titre against your specific lysate or fluid to establish your optimal working concentration.

Is this Serpin-A11 antibody cross-reactive with mouse or rat samples?

This antibody is validated for human Serpin-A11. Cross-reactivity with mouse or rat has not been experimentally confirmed. Human SERPINA11 shares moderate sequence homology with rodent orthologs, so cross-reactivity is possible but not guaranteed. If you plan to work with mouse or rat samples, we recommend running a pilot blot with positive control human plasma alongside your rodent sample. Check for a band at the expected molecular weight and verify specificity with a blocking peptide or Serpin-A11 knockout lysate if available.

What sample types are best for detecting Serpin-A11?

Serpin-A11 is a secreted protein, so plasma, serum, and cell culture supernatants are the most reliable sample types. It has been detected in exosomal fractions as well. If using cell lysates, prioritize cell lines known to secrete Serpin-A11 or those relevant to cardiovascular and metabolic contexts where expression has been reported. For tissue work, consider organs with high secretory activity or vascular beds. Avoid whole-blood lysates unless you are specifically investigating circulating levels; plasma separation provides cleaner background and higher signal-to-noise.

Does Serpin-A11 have splice variants or isoforms I should be aware of?

Serpin-A11 is encoded by a single-exon mature coding sequence with limited evidence for functionally distinct splice isoforms in the literature. The canonical form is 422 amino acids after signal-peptide cleavage. Minor variants may exist at the transcript level, but they are not well characterized. This polyclonal antibody is raised against a large portion of the mature protein and should recognize the predominant circulating form. If you observe multiple bands on Western blot, consider post-translational modifications such as glycosylation or proteolytic processing rather than isoforms.

Can I use this antibody for immunohistochemistry or immunofluorescence?

Triple Point Biologics antibodies are routinely validated for Western blot and immunohistochemistry, and many perform well in immunofluorescence. This Serpin-A11 rabbit polyclonal has been validated for Western blot at 1:1000; IHC is supported across our product line. For IHC, start with 1:100 to 1:200 dilution and antigen retrieval in citrate buffer. For IF, begin at 1:50 to 1:100. Because Serpin-A11 is secreted, expect extracellular and perivascular staining in tissues. Validate specificity with a no-primary-antibody control and confirm expression pattern against known Serpin-A11–expressing tissues.

How should I store this Serpin-A11 antibody and what is its shelf life?

Store the antibody at –20 °C in single-use aliquots to avoid repeated freeze-thaw cycles, which can reduce titre and increase aggregation. The product is supplied at 100 µg and is stable for at least 12 months under these conditions. For short-term use, an aliquot can be kept at 4 °C for up to one month. Add sodium azide to a final concentration of 0.02–0.05 percent if storing at 4 °C for extended periods. Do not store diluted antibody; prepare working dilutions fresh in blocking buffer on the day of use.

What controls should I include when working with Serpin-A11 antibody?

Always include a positive control known to contain Serpin-A11, such as human plasma or serum, which will show a band at approximately 47–50 kDa. A negative control could be a cell line or tissue with negligible Serpin-A11 expression. If available, use a blocking peptide corresponding to the immunogen to confirm specificity; pre-incubate antibody with peptide and verify signal loss. For quantitative work or biomarker studies, run a dilution series of your positive control to assess linearity and dynamic range. Secondary-antibody-only lanes help rule out non-specific binding.

Validation imagery coming soon

Western blot validation figures for RP-SerpinA11 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • SERPINA11
  • Serpin A11
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →